Lori E. Dodd
About
Lori E. Dodd is a scholar working on Statistics and Probability, Epidemiology and Infectious Diseases.
According to data from OpenAlex, Lori E. Dodd has authored 72 papers receiving a total of 24.2k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Statistics and Probability, 21 papers in Epidemiology and 20 papers in Infectious Diseases. Recurrent topics in Lori E. Dodd's work include Statistical Methods in Clinical Trials (22 papers), Health Systems, Economic Evaluations, Quality of Life (10 papers) and Tuberculosis Research and Epidemiology (9 papers). Lori E. Dodd is often cited by papers focused on Statistical Methods in Clinical Trials (22 papers), Health Systems, Economic Evaluations, Quality of Life (10 papers) and Tuberculosis Research and Epidemiology (9 papers). Lori E. Dodd collaborates with scholars based in United States, South Africa and United Kingdom. Lori E. Dodd's co-authors include Janet Dancey, Larry Rubinstein, Lawrence H. Schwartz, Lalitha Shankar, Margaret Mooney, Daniel J. Sargent, P. Therasse, Richard Kaplan, E. Eisenhauer and Stephen J. Gwyther and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Journal of the American Statistical Association.
In The Last Decade
Lori E. Dodd
71 papers receiving 23.9k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Lori E. Dodd United States | 28 | 11.4k | 9.5k | 4.4k | 4.2k | 3.6k | 72 | 24.2k | ||
| Jaco J. Verweij Netherlands | 52 | 12.4k 1.1× | 9.8k 1.0× | 4.1k 0.9× | 4.9k 1.2× | 3.6k 1.0× | 223 | 29.8k | ||
| P. Therasse Belgium | 27 | 12.4k 1.1× | 10.5k 1.1× | 4.6k 1.1× | 4.2k 1.0× | 4.2k 1.2× | 57 | 24.1k | ||
| Volker Heinemann Germany | 67 | 14.5k 1.3× | 6.2k 0.7× | 1.3k 0.3× | 3.9k 0.9× | 4.3k 1.2× | 666 | 20.3k | ||
| Mahesh Parmar United Kingdom | 71 | 8.3k 0.7× | 11.0k 1.2× | 2.8k 0.6× | 6.7k 1.6× | 2.4k 0.7× | 299 | 27.0k | ||
| Anthony T.�C. Chan Hong Kong | 86 | 11.7k 1.0× | 5.6k 0.6× | 1.7k 0.4× | 7.2k 1.7× | 6.1k 1.7× | 456 | 27.6k | ||
| Solange Peters Switzerland | 73 | 19.6k 1.7× | 17.8k 1.9× | 2.3k 0.5× | 1.8k 0.4× | 4.7k 1.3× | 427 | 30.5k | ||
| J. Han van Krieken Netherlands | 73 | 12.9k 1.1× | 5.2k 0.5× | 1.4k 0.3× | 6.8k 1.6× | 2.8k 0.8× | 380 | 23.6k | ||
| F. Stephen Hodi United States | 101 | 34.2k 3.0× | 9.8k 1.0× | 2.8k 0.6× | 2.7k 0.6× | 3.4k 0.9× | 517 | 44.0k | ||
| Jean‐Pierre Pignon France | 77 | 14.8k 1.3× | 16.3k 1.7× | 2.6k 0.6× | 8.9k 2.1× | 2.8k 0.8× | 305 | 31.0k | ||
| Theodore S. Lawrence United States | 87 | 8.7k 0.8× | 8.2k 0.9× | 7.9k 1.8× | 3.1k 0.7× | 3.9k 1.1× | 622 | 28.0k |
Countries citing papers authored by Lori E. Dodd
Since
Specialization
Citations
This map shows the geographic impact of Lori E. Dodd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lori E. Dodd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lori E. Dodd more than expected).
Fields of papers citing papers by Lori E. Dodd
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Lori E. Dodd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lori E. Dodd. The network helps show where Lori E. Dodd may publish in the future.
Co-authorship network of co-authors of Lori E. Dodd
This figure shows the co-authorship network connecting the top 25 collaborators of Lori E. Dodd. A scholar is included among the top collaborators of Lori E. Dodd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lori E. Dodd. Lori E. Dodd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Dijck, Christophe Van, Ian Crozier, Koen Vercauteren, et al.. (2023). Beware of drug resistance: Let’s not lose tecovirimat against mpox. Clinical Microbiology and Infection. 30(3). 276–278.
2.
Mbala‐Kingebeni, Placide, Olivier Tshiani Mbaya, Lori E. Dodd, et al.. (2022). Counting Monkeypox Lesions in Patient Photographs: Limits of Agreement of Manual Counts and Artificial Intelligence. Journal of Investigative Dermatology. 143(2). 347–350.e4.
3.
Fintzi, Jonathan, Tyler Bonnett, Daniel A. Sweeney, et al.. (2021). Deconstructing the Treatment Effect of Remdesivir in the Adaptive Coronavirus Disease 2019 (COVID-19) Treatment Trial-1: Implications for Critical Care Resource Utilization. Clinical Infectious Diseases. 74(12). 2209–2217.
4.
Sinharay, Sanhita, Swati Shah, Jing Wang, et al.. (2018). Brain 18F-FDG PET of SIV-infected macaques after treatment interruption or initiation. Journal of Neuroinflammation. 15(1). 207–207.
5.
Lau, Chuen‐Yen, Andrew D. Mihalek, Jing Wang, et al.. (2016). Pulmonary Manifestations of the Autoimmune Lymphoproliferative Syndrome. A Retrospective Study of a Unique Patient Cohort. Annals of the American Thoracic Society. 13(8). 1279–1288.
6.
Shenai, Shubhada, Katharina Ronacher, Kim Stanley, et al.. (2016). Bacterial Loads Measured by the Xpert MTB/RIF Assay as Markers of Culture Conversion and Bacteriological Cure in Pulmonary TB. PLoS ONE. 11(8). e0160062–e0160062.
7.
Colombo, Rhonda E, Lori E. Dodd, Sally Hunsberger, et al.. (2015). A phase 1 randomized, double-blind, placebo-controlled, crossover trial of DAS181 (Fludase®) in adult subjects with well-controlled asthma. BMC Infectious Diseases. 16(1). 54–54.
8.
Dodd, Lori E., Reed F. Johnson, Joseph E. Blaney, & Dean Follmann. (2014). Matched Longitudinal Analysis of Biomarkers Associated with Survival. Clinical and Vaccine Immunology. 21(8). 1145–1152.
9.
Wentzensen, Nicolas, Martha Nason, Mark Schiffman, et al.. (2013). No Evidence for Synergy Between Human Papillomavirus Genotypes for the Risk of High-Grade Squamous Intraepithelial Lesions in a Large Population-Based Study. The Journal of Infectious Diseases. 209(6). 855–864.
10.
Dodd, Lori E., Edward L. Korn, Boris Freidlin, et al.. (2013). An audit strategy for time-to-event outcomes measured with error: Application to five randomized controlled trials in oncology. Clinical Trials. 10(5). 754–760.
11.
Marais, Suzaan, Graeme Meintjes, Dominique J. Pepper, et al.. (2012). Frequency, Severity, and Prediction of Tuberculous Meningitis Immune Reconstitution Inflammatory Syndrome. Clinical Infectious Diseases. 56(3). 450–460.
12.
Georgoff, Patrick, David Thomasson, Adeline Louie, et al.. (2012). Hydrogen-1 MR Spectroscopy for Measurement and Diagnosis of Hepatic Steatosis. American Journal of Roentgenology. 199(1). 2–7.
13.
Porras, Carolina, Lori E. Dodd, Allan Hildesheim, et al.. (2011). Evaluation of the Polyclonal ELISA HPV Serology Assay as a Biomarker for Human Papillomavirus Exposure. Sexually Transmitted Diseases. 38(10). 976–982.
14.
Kuhn, Jens H., Lori E. Dodd, Victoria Wahl‐Jensen, et al.. (2011). Evaluation of Perceived Threat Differences Posed by Filovirus Variants. Biosecurity and Bioterrorism Biodefense Strategy Practice and Science. 9(4). 361–371.
15.
Garcı́a-Piñeres, Alfonso, Allan Hildesheim, Lori E. Dodd, et al.. (2009). Gene Expression Patterns Induced by HPV-16 L1 Virus-Like Particles in Leukocytes from Vaccine Recipients. The Journal of Immunology. 182(3). 1706–1729.
16.
Eisenhauer, E., P. Therasse, Jan Bogaerts, et al.. (2008). New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). European Journal of Cancer. 45(2). 228–247.
17.
Dancey, Janet, Lori E. Dodd, Robert Ford, et al.. (2008). Recommendations for the assessment of progression in randomised cancer treatment trials. European Journal of Cancer. 45(2). 281–289.
18.
Sargent, Daniel J., Larry Rubinstein, Lawrence H. Schwartz, et al.. (2008). Validation of novel imaging methodologies for use as cancer clinical trial end-points. European Journal of Cancer. 45(2). 290–299.
19.
Dodd, Lori E., Srikumar Sengupta, I‐How Chen, et al.. (2006). Genes Involved in DNA Repair and Nitrosamine Metabolism and Those Located on Chromosome 14q32 Are Dysregulated in Nasopharyngeal Carcinoma. Cancer Epidemiology Biomarkers & Prevention. 15(11). 2216–2225.
20.
Albert, Paul S. & Lori E. Dodd. (2004). A Cautionary Note on the Robustness of Latent Class Models for Estimating Diagnostic Error without a Gold Standard. Biometrics. 60(2). 427–435.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Jaco J. Verweij Breakdown of academic impact, for papers by P. Therasse Breakdown of academic impact, for papers by Volker Heinemann Breakdown of academic impact, for papers by Mahesh Parmar Breakdown of academic impact, for papers by Anthony T.�C. Chan Breakdown of academic impact, for papers by Solange Peters Breakdown of academic impact, for papers by J. Han van Krieken Breakdown of academic impact, for papers by F. Stephen Hodi Breakdown of academic impact, for papers by Jean‐Pierre Pignon Breakdown of academic impact, for papers by Theodore S. Lawrence